Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck will establish an Asia Research & Development (R&D) headquarters in Beijing, China for drug discovery and development, as part of the company's $1.5bn investment in R&D in China over the next five years.
Subscribe to our email newsletter
The 47,000m² of the facility will take charge of drug discovery, translational research, clinical development, regulatory affairs and external scientific research programs.
The first phase of construction is scheduled to be completed by 2014.
Merck Research Laboratories president Peter S Kim said the new facility would be a key milestone in their growth strategy.
"By strategically locating in China, we are able to complement our existing R&D capabilities, and facilitate new collaborations with scientists in the region and across emerging markets," Kim added.